| The transmissibility and control of pandemic influenza A (H1N1) virus Y Yang, JD Sugimoto, ME Halloran, NE Basta, DL Chao, L Matrajt, ... Science 326 (5953), 729-733, 2009 | 715 | 2009 |
| Evaluating the Effectiveness of Social Distancing Interventions to Delay or Flatten the Epidemic Curve of Coronavirus Disease. L Matrajt, T Leung Emerging Infectious Diseases 26 (8), 2020 | 509 | 2020 |
| Vaccine optimization for COVID-19: Who to vaccinate first? L Matrajt, J Eaton, T Leung, ER Brown Science Advances 7 (6), eabf1374, 2021 | 408 | 2021 |
| Strategies for pandemic and seasonal influenza vaccination of schoolchildren in the United States NE Basta, DL Chao, ME Halloran, L Matrajt, IM Longini American journal of epidemiology 170 (6), 679-686, 2009 | 195 | 2009 |
| Optimizing vaccine allocation for COVID-19 vaccines shows the potential role of single-dose vaccination L Matrajt, J Eaton, T Leung, D Dimitrov, JT Schiffer, DA Swan, H Janes Nature communications 12 (1), 3449, 2021 | 138 | 2021 |
| Estimating influenza vaccine efficacy from challenge and community-based study data NE Basta, ME Halloran, L Matrajt, IM Longini Jr American Journal of Epidemiology 168 (12), 1343-1352, 2008 | 109 | 2008 |
| The global transmission and control of influenza E Kenah, DL Chao, L Matrajt, ME Halloran, IM Longini Jr PloS one 6 (5), e19515, 2011 | 104 | 2011 |
| COVID-19 vaccines that reduce symptoms but do not block infection need higher coverage and faster rollout to achieve population impact DA Swan, C Bracis, H Janes, M Moore, L Matrajt, DB Reeves, E Burns, ... Scientific reports 11 (1), 15531, 2021 | 93 | 2021 |
| Optimizing vaccine allocation at different points in time during an epidemic L Matrajt, IM Longini Jr PLoS One 5 (11), e13767, 2010 | 71 | 2010 |
| Optimal vaccine allocation for the early mitigation of pandemic influenza L Matrajt, ME Halloran, IM Longini Jr PLoS computational biology 9 (3), e1002964, 2013 | 70 | 2013 |
| Planning for the control of pandemic influenza A (H1N1) in Los Angeles County and the United States DL Chao, L Matrajt, NE Basta, JD Sugimoto, B Dean, DA Bagwell, ... American journal of epidemiology 173 (10), 1121-1130, 2011 | 47 | 2011 |
| Achieving coordinated national immunity and cholera elimination in Haiti through vaccination: a modelling study EC Lee, DL Chao, JC Lemaitre, L Matrajt, D Pasetto, J Perez-Saez, ... The Lancet Global Health 8 (8), e1081-e1089, 2020 | 34 | 2020 |
| Dynamics of persistent oral cytomegalovirus shedding during primary infection in Ugandan infants BT Mayer, L Matrajt, C Casper, EM Krantz, L Corey, A Wald, S Gantt, ... The Journal of infectious diseases 214 (11), 1735-1743, 2016 | 34 | 2016 |
| The Majority of CD4+ T-Cell Depletion during Acute Simian-Human Immunodeficiency Virus SHIV89.6P Infection Occurs in Uninfected Cells L Matrajt, PM Younan, HP Kiem, JT Schiffer Journal of virology 88 (6), 3202-3212, 2014 | 34 | 2014 |
| Could widespread use of antiviral treatment curb the COVID-19 pandemic? A modeling study L Matrajt, ER Brown, MS Cohen, D Dimitrov, H Janes BMC Infectious Diseases 22 (1), 683, 2022 | 27 | 2022 |
| Critical immune and vaccination thresholds for determining multiple influenza epidemic waves L Matrajt, IM Longini Jr Epidemics 4 (1), 22-32, 2012 | 27 | 2012 |
| One versus two doses: What is the best use of vaccine in an influenza pandemic? L Matrajt, T Britton, ME Halloran, IM Longini Jr Epidemics 13, 17-27, 2015 | 25 | 2015 |
| Virus and host-specific differences in oral human herpesvirus shedding kinetics among Ugandan women and children L Matrajt, S Gantt, BT Mayer, EM Krantz, J Orem, A Wald, L Corey, ... Scientific reports 7 (1), 13105, 2017 | 22 | 2017 |
| Successes and failures of the live-attenuated influenza vaccine: can we do better? L Matrajt, ME Halloran, R Antia Clinical Infectious Diseases 70 (6), 1029-1037, 2020 | 19 | 2020 |
| Protection afforded by previous Vibrio cholerae infection against subsequent disease and infection: A review T Leung, L Matrajt PLOS Neglected Tropical Diseases 15 (5), e0009383, 2021 | 10 | 2021 |
